Zeitschriftenartikel zum Thema „Targeted nanotherapy“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Targeted nanotherapy" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Kim, Gloria J., und Shuming Nie. „Targeted cancer nanotherapy“. Materials Today 8, Nr. 8 (August 2005): 28–33. http://dx.doi.org/10.1016/s1369-7021(05)71034-8.
Der volle Inhalt der QuelleMathew, Anila, Toru Maekawa und D. Sakthikumar. „Aptamers in Targeted Nanotherapy“. Current Topics in Medicinal Chemistry 15, Nr. 12 (17.04.2015): 1102–14. http://dx.doi.org/10.2174/1568026615666150413153525.
Der volle Inhalt der QuelleZhu, Peng, Carl Atkinson, Suraj Dixit, Qi Cheng, Danh Tran, Kunal Patel, Yu-Lin Jiang et al. „Organ preservation with targeted rapamycin nanoparticles: a pre-treatment strategy preventing chronic rejection in vivo“. RSC Advances 8, Nr. 46 (2018): 25909–19. http://dx.doi.org/10.1039/c8ra01555d.
Der volle Inhalt der QuelleCrintea, Andreea, Anne-Marie Constantin, Alexandru C. Motofelea, Carmen-Bianca Crivii, Maria A. Velescu, Răzvan L. Coșeriu, Tamás Ilyés, Alexandra M. Crăciun und Ciprian N. Silaghi. „Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer“. Journal of Functional Biomaterials 14, Nr. 9 (09.09.2023): 466. http://dx.doi.org/10.3390/jfb14090466.
Der volle Inhalt der QuelleNarayanan, Sreeja, N. S. Binulal, Ullas Mony, Koyakutty Manzoor, Shantikumar Nair und Deepthy Menon. „Folate targeted polymeric ‘green’ nanotherapy for cancer“. Nanotechnology 21, Nr. 28 (28.06.2010): 285107. http://dx.doi.org/10.1088/0957-4484/21/28/285107.
Der volle Inhalt der QuelleKatsogiannou, M., L. Peng, C. V. Catapano und P. Rocchi. „Active-Targeted Nanotherapy Strategies for Prostate Cancer“. Current Cancer Drug Targets 11, Nr. 8 (01.10.2011): 954–65. http://dx.doi.org/10.2174/156800911797264770.
Der volle Inhalt der QuelleMetcalfe, Su M., und Tarek M. Fahmy. „Targeted nanotherapy for induction of therapeutic immune responses“. Trends in Molecular Medicine 18, Nr. 2 (Februar 2012): 72–80. http://dx.doi.org/10.1016/j.molmed.2011.11.002.
Der volle Inhalt der QuelleHu, Xiankang, und Jianxiang Zhang. „Yeast capsules for targeted delivery: the future of nanotherapy?“ Nanomedicine 12, Nr. 9 (Mai 2017): 955–57. http://dx.doi.org/10.2217/nnm-2017-0059.
Der volle Inhalt der QuelleRapoport, N. Ya, K. H. Nam, Z. Gao und A. Kennedy. „Application of ultrasound for targeted nanotherapy of malignant tumors“. Acoustical Physics 55, Nr. 4-5 (18.07.2009): 594–601. http://dx.doi.org/10.1134/s1063771009040162.
Der volle Inhalt der QuelleSoodgupta, Deepti, Dipanjan Pan, Grace Hu, Angana Senpan, Xiaoxia Yang, Katherine N. Weilbaecher, Edward V. Prochownik, Gregory M. Lanza und Michael H. Tomasson. „Preclinical Development Of a Nanomedicne Approach For Multiple Myeloma Targeting The Myc Oncoprotein“. Blood 122, Nr. 21 (15.11.2013): 4228. http://dx.doi.org/10.1182/blood.v122.21.4228.4228.
Der volle Inhalt der QuelleKoneru, Tejaswi, Eva McCord, Shreya Pawar, Katyayani Tatiparti, Samaresh Sau und Arun K. Iyer. „Transferrin: Biology and Use in Receptor-Targeted Nanotherapy of Gliomas“. ACS Omega 6, Nr. 13 (22.03.2021): 8727–33. http://dx.doi.org/10.1021/acsomega.0c05848.
Der volle Inhalt der QuelleKeen, Judith C. „A step towards a new targeted nanotherapy for pancreatic cancer“. Cancer Biology & Therapy 7, Nr. 10 (Oktober 2008): 1591–92. http://dx.doi.org/10.4161/cbt.7.10.6758.
Der volle Inhalt der QuelleZhou, Xia-Qing, Ya-Ping Li und Shuang-Suo Dang. „Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy“. World Journal of Hepatology 16, Nr. 2 (27.02.2024): 164–76. http://dx.doi.org/10.4254/wjh.v16.i2.164.
Der volle Inhalt der QuelleMarcelo, Gonçalo A., David Montpeyó, Joana Galhano, Ramón Martínez-Máñez, José Luis Capelo-Martínez, Julia Lorenzo, Carlos Lodeiro und Elisabete Oliveira. „Development of New Targeted Nanotherapy Combined with Magneto-Fluorescent Nanoparticles against Colorectal Cancer“. International Journal of Molecular Sciences 24, Nr. 7 (01.04.2023): 6612. http://dx.doi.org/10.3390/ijms24076612.
Der volle Inhalt der QuelleAwad, Noor A., Nahi Y. Yassen, Amer T. Tawfeeq und Kismat M. Turki. „Hybrid nanoliposome as a targeted growth inhibitor for Cervical Carcinoma Cell line“. Journal of the Faculty of Medicine Baghdad 57, Nr. 4 (03.01.2016): 320–24. http://dx.doi.org/10.32007/jfacmedbagdad.574399.
Der volle Inhalt der QuelleAsik, Elif, Yeliz Akpinar, Ayse Caner, Nermin Kahraman, Tulin Guray, Murvet Volkan, Constance Albarracin, Apar Pataer, Banu Arun und Bulent Ozpolat. „EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppressesBRCA1-mutated breast cancer“. Nanomedicine 14, Nr. 17 (September 2019): 2315–38. http://dx.doi.org/10.2217/nnm-2019-0132.
Der volle Inhalt der QuelleZhou, Hui-fang, Happy W. Chan, Samuel A. Wickline, Gregory M. Lanza und Christine T. N. Pham. „α v β 3 –Targeted nanotherapy suppresses inflammatory arthritis in mice“. FASEB Journal 23, Nr. 9 (17.04.2009): 2978–85. http://dx.doi.org/10.1096/fj.09-129874.
Der volle Inhalt der QuelleJournaux, Justine, M. Bejko, P. Clerc, Y. Al Yaman, C. Bousquet, S. Mornet, O. Sandre und V. Gigoux. „Nanotherapy of pancreatic adenocarcinoma by targeted magnetic hyperthermia: efficacy and mechanisms.“ Pancreatology 22 (November 2022): e74-e75. http://dx.doi.org/10.1016/j.pan.2022.06.193.
Der volle Inhalt der QuelleHaque, Sakib, Kiri Cook, Gaurav Sahay und Conroy Sun. „RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer“. Pharmaceutics 13, Nr. 10 (15.10.2021): 1694. http://dx.doi.org/10.3390/pharmaceutics13101694.
Der volle Inhalt der QuelleKara, Goknur, Pinar Atalay Dundar, Nermin Kahraman, Emir Baki Denkbas und Bulent Ozpolat. „Abstract 461: Dual-kinase targeted miRNA nanotherapy for the treatment of triple-negative breast cancer“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 461. http://dx.doi.org/10.1158/1538-7445.am2024-461.
Der volle Inhalt der QuelleSajjadi, Mohaddeseh, Mahmoud Nasrollahzadeh, Babak Jaleh, Ghazaleh Jamalipour Soufi und Siavash Iravani. „Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects“. Journal of Drug Targeting 29, Nr. 7 (18.02.2021): 716–41. http://dx.doi.org/10.1080/1061186x.2021.1886301.
Der volle Inhalt der QuelleKAJIMOTO, Kazuaki. „Adipose Vasculature Targeted Nanotherapy Leads to a Novel Strategy of Obesity Treatment“. Oleoscience 15, Nr. 3 (2015): 107–14. http://dx.doi.org/10.5650/oleoscience.15.107.
Der volle Inhalt der QuelleKomizu, Yuji, Sayuri Nakata, Koichi Goto, Yoko Matsumoto und Ryuichi Ueoka. „Membrane-Targeted Nanotherapy with Hybrid Liposomes for Tumor Cells Leading to Apoptosis“. ACS Medicinal Chemistry Letters 2, Nr. 4 (13.01.2011): 275–79. http://dx.doi.org/10.1021/ml100269t.
Der volle Inhalt der QuelleAgrahari, Vivek. „The exciting potential of nanotherapy in brain-tumor targeted drug delivery approaches“. Neural Regeneration Research 12, Nr. 2 (2017): 197. http://dx.doi.org/10.4103/1673-5374.200796.
Der volle Inhalt der QuelleDelie, Florence, Patrick Petignat und Marie Cohen. „GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78“. Targeted Oncology 8, Nr. 4 (23.10.2012): 225–30. http://dx.doi.org/10.1007/s11523-012-0234-9.
Der volle Inhalt der QuelleNguyen, Dai Hai, Jung Seok Lee, Jin Woo Bae, Jong Hoon Choi, Yunki Lee, Joo Young Son und Ki Dong Park. „Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice“. International Journal of Pharmaceutics 495, Nr. 1 (November 2015): 329–35. http://dx.doi.org/10.1016/j.ijpharm.2015.08.083.
Der volle Inhalt der QuellePan, Dipanjan, Benjamin Kim, Grace Hu, Deepti Sood Gupta, Angana Senpan, Xiaoxia Yang, Anne Schmieder et al. „A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy“. Nanomedicine 10, Nr. 2 (Januar 2015): 241–51. http://dx.doi.org/10.2217/nnm.14.101.
Der volle Inhalt der QuelleRoss, Michael H., Alison K. Esser, Gregory C. Fox, Anne H. Schmieder, Xiaoxia Yang, Grace Hu, Dipanjan Pan et al. „Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases“. Cancer Research 77, Nr. 22 (30.08.2017): 6299–312. http://dx.doi.org/10.1158/0008-5472.can-17-1225.
Der volle Inhalt der QuelleWang, Xiaoxuan, Fangxuan Li, Jialu Zhang, Lu Guo, Mengmeng Shang, Xiao Sun, Shan Xiao et al. „A combination of PD-L1-targeted IL-15 mRNA nanotherapy and ultrasound-targeted microbubble destruction for tumor immunotherapy“. Journal of Controlled Release 367 (März 2024): 45–60. http://dx.doi.org/10.1016/j.jconrel.2024.01.039.
Der volle Inhalt der QuelleZhang, Qixiong, Fuzhong Zhang, Shanshan Li, Renfeng Liu, Taotao Jin, Yin Dou, Zhenhua Zhou und Jianxiang Zhang. „A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment“. Theranostics 9, Nr. 13 (2019): 3732–53. http://dx.doi.org/10.7150/thno.34377.
Der volle Inhalt der QuellePuligujja, Pavan, Mariluz Araínga, Prasanta Dash, Diana Palandri, R. Lee Mosley, Santhi Gorantla, Larisa Poluektova, JoEllyn McMillan und Howard E. Gendelman. „Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice“. Antiviral Research 120 (August 2015): 85–88. http://dx.doi.org/10.1016/j.antiviral.2015.05.009.
Der volle Inhalt der QuelleNg, Thomas S. C., David Wert, Hargun Sohi, Daniel Procissi, David Colcher, Andrew A. Raubitschek und Russell E. Jacobs. „Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101“. Clinical Cancer Research 19, Nr. 9 (26.03.2013): 2518–27. http://dx.doi.org/10.1158/1078-0432.ccr-12-2738.
Der volle Inhalt der QuelleSong, Xinhao, Mengjuan Lin, Tian Fang, Jiahao Gong, Junqi Wang, Shasha Gao, Xiaolin Xu et al. „Maduramicin-guided nanotherapy: A polymeric micelles for targeted drug delivery in canine mammary tumors“. Biomedicine & Pharmacotherapy 170 (Januar 2024): 116062. http://dx.doi.org/10.1016/j.biopha.2023.116062.
Der volle Inhalt der QuelleJiang, Quzi, Luodan Yu und Yu Chen. „Engineering Self-Assembled Nanomedicines Composed of Clinically Approved Medicines for Enhanced Tumor Nanotherapy“. Nanomaterials 13, Nr. 18 (05.09.2023): 2499. http://dx.doi.org/10.3390/nano13182499.
Der volle Inhalt der QuelleGolzar, Hossein, Fatemeh Yazdian, Mohadeseh Hashemi, Meisam Omidi, Dorsa Mohammadrezaei, Hamid Rashedi, Masoumeh Farahani, Nazanin Ghasemi, Javad Shabani shayeh und Lobat Tayebi. „Optimizing the hybrid nanostructure of functionalized reduced graphene oxide/silver for highly efficient cancer nanotherapy“. New Journal of Chemistry 42, Nr. 15 (2018): 13157–68. http://dx.doi.org/10.1039/c8nj01764f.
Der volle Inhalt der QuelleJanani, Balakarthikeyan, Mayakrishnan Vijayakumar, Kannappan Priya, Jin Hee Kim, D. S. Prabakaran, Mohammad Shahid, Sameer Al-Ghamdi et al. „EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges“. Vaccines 10, Nr. 4 (24.03.2022): 499. http://dx.doi.org/10.3390/vaccines10040499.
Der volle Inhalt der QuelleLin, Mingzhen, Lili Teng, Yang Wang, Jiaxin Zhang und Xianglian Sun. „Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy“. Drug Delivery 23, Nr. 4 (23.07.2015): 1420–25. http://dx.doi.org/10.3109/10717544.2015.1066902.
Der volle Inhalt der QuelleKhan, Suliman, Majid Sharifi, Jason P. Gleghorn, Mohammad Mahdi Nejadi Babadaei, Samir Haj Bloukh, Zehra Edis, Mohammadreza Amin et al. „Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy“. Journal of Controlled Release 348 (August 2022): 127–47. http://dx.doi.org/10.1016/j.jconrel.2022.05.055.
Der volle Inhalt der QuelleZhang, Jin. „The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis“. Journal of Healthcare Engineering 2021 (26.11.2021): 1–6. http://dx.doi.org/10.1155/2021/3982158.
Der volle Inhalt der QuelleGupta, Tanvi, Tilahun Ayane Debele, Yu-Feng Wei, Anish Gupta, Mohd Murtaza und Wen-Pin Su. „Synergistic Action of Immunotherapy and Nanotherapy against Cancer Patients Infected with SARS-CoV-2 and the Use of Artificial Intelligence“. Cancers 14, Nr. 1 (02.01.2022): 213. http://dx.doi.org/10.3390/cancers14010213.
Der volle Inhalt der QuelleMitri, Fabio Franceschini. „Advances of the Nanotechnology in Targeted Nanomedicines for Treatment of Bone Cancers and Diseases“. Journal of Cancer Research Updates 10 (30.12.2021): 32–45. http://dx.doi.org/10.30683/1929-2279.2021.10.05.
Der volle Inhalt der QuelleWu, Jianrong, Zheying Meng, Agata A. Exner, Xiaojun Cai, Xue Xie, Bing Hu, Yu Chen und Yuanyi Zheng. „Biodegradable cascade nanocatalysts enable tumor-microenvironment remodeling for controllable CO release and targeted/synergistic cancer nanotherapy“. Biomaterials 276 (September 2021): 121001. http://dx.doi.org/10.1016/j.biomaterials.2021.121001.
Der volle Inhalt der QuelleYoo, Byunghee, Amol Kavishwar, Alana Ross, Ping Wang, Doris P. Tabassum, Kornelia Polyak, Natalia Barteneva et al. „Combining miR-10b–Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer“. Cancer Research 75, Nr. 20 (10.09.2015): 4407–15. http://dx.doi.org/10.1158/0008-5472.can-15-0888.
Der volle Inhalt der QuelleBariana, Manpreet, Beilu Zhang, Jingyu Sun, Elena Cassella, Janice Rateshwar, Ming Tony Tan, Weiwei Wang et al. „Targeted Nanotherapy of Hematologic Malignancies Using Gold Nanoframework-Based Delivery of a Novel NF-Kb Inhibitor“. Blood 140, Supplement 1 (15.11.2022): 6018–19. http://dx.doi.org/10.1182/blood-2022-160324.
Der volle Inhalt der QuelleTrandafir, Laura M., Gianina Dodi, Otilia Frasinariu, Alina C. Luca, Lacramioara I. Butnariu, Elena Tarca und Stefana M. Moisa. „Tackling Dyslipidemia in Obesity from a Nanotechnology Perspective“. Nutrients 14, Nr. 18 (13.09.2022): 3774. http://dx.doi.org/10.3390/nu14183774.
Der volle Inhalt der QuelleReddy, Hrushikesh, G. Jyothi, Maheshwari, D.Prasad und M.Sudhakar. „Nanoliposomes-A Review“. World Journal of Pharmaceutical Sciences 10, Nr. 03 (2022): 299–307. http://dx.doi.org/10.54037/wjps.2022.100308.
Der volle Inhalt der QuelleSILVA, ADRIANA L. DA, RAQUEL S. SANTOS, DÉBORA G. XISTO, SILVIA DEL V. ALONSO, MARCELO M. MORALES und PATRICIA R. M. ROCCO. „Nanoparticle-based therapy for respiratory diseases“. Anais da Academia Brasileira de Ciências 85, Nr. 1 (05.03.2013): 137–46. http://dx.doi.org/10.1590/s0001-37652013005000018.
Der volle Inhalt der QuelleMahajan, Supriya, Ravikumar Aalinkeel, Jessica Reynolds, Bindukumar Nair, Donald Sykes, Wing-Cheung Law, Paras Prasad und Stanley Schwartz. „Innovative nanotherapy for the treatment of the chronic skin condition, rosacea. (P3259)“. Journal of Immunology 190, Nr. 1_Supplement (01.05.2013): 192.15. http://dx.doi.org/10.4049/jimmunol.190.supp.192.15.
Der volle Inhalt der QuelleNewton, Emily R., David C. Gillis, Kui Sun, Brooke R. Dandurand, Robin Siletzky, Suvendu Biswas, Mark R. Karver, Nick D. Tsihlis, Samuel I. Stupp und Melina R. Kibbe. „Evaluation of a Targeted Drug‐Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model“. Advanced NanoBiomed Research 1, Nr. 7 (03.05.2021): 2000093. http://dx.doi.org/10.1002/anbr.202000093.
Der volle Inhalt der QuelleHalling Folkmar Andersen, Anna, und Martin Tolstrup. „The Potential of Long-Acting, Tissue-Targeted Synthetic Nanotherapy for Delivery of Antiviral Therapy Against HIV Infection“. Viruses 12, Nr. 4 (07.04.2020): 412. http://dx.doi.org/10.3390/v12040412.
Der volle Inhalt der Quelle